Giannis Mountzios: SCLC Therapeutic Landscape is Rapidly Changing
Giannis Mountzios, Director of the 4th Oncology Department and Clinical Trials Unit at Henry Dunant Hospital Center, shared a post on LinkedIn: “SCLC therapeutic landscape is rapidly changing, with…
Read the full articleYou might also wanna read
Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cells
Deep phenotyping reveals that CD19-CAR T cell therapy in SSc patients shows potential in reversing skin fibrosis. Explore how molecular insi
<![CDATA[Outpatient BiTE Therapy Model Expands Access for Patients With Multiple Myeloma]]>
Navigating the Complex Landscape of Cell and Gene Therapy Manufacturing
Consultants from ProPharma express optimism about the trajectory of cell and gene therapy despite technical and logistical difficulties rema
MSCopilot Detect emerges as early contender for scalable remote MS monitoring, says GlobalData
Digital biomarkers are gaining momentum in multiple sclerosis (MS) care, with new findings highlighting the potential of smartphone-based as
Real-world data point to patient experience as next battleground for anti-CD20 therapies in RMS, says GlobalData
As real-world evidence (RWE) increasingly shapes competition in the relapsing multiple sclerosis (RMS) market, TG Therapeutics is leaning on
CancerNetwork: Historical Evolution and Current Treatment Landscape
The post CancerNetwork: Historical Evolution and Current Treatment Landscape appeared first on UNC Lineberger Comprehensive Cancer Center .
Comments
Sign in to join the conversation.
No comments yet. Be the first.